MeSH D003704 - dementia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D019965:Neurocognitive disorders
0 Companies
0 Drugs
Success rate
D001927:Brain diseases
0 Companies
0 Drugs
Success rate
D003704:Â
Dementia
D000544:Alzheimer disease
D006816:Huntington disease
D007562:Creutzfeldt-jakob syndrome
0 Companies
0 Drugs
Success rate
D015140:Vascular dementia
0 Companies
0 Drugs
Success rate
D015526:Aids dementia complex
0 Companies
0 Drugs
Success rate
D018888:Primary progressive aphasia
0 Companies
0 Drugs
Success rate
D020232:Kluver-bucy syndrome
0 Companies
0 Drugs
Success rate
D055956:Diffuse neurofibrillary tangles with calcification
0 Companies
0 Drugs
Success rate
D057174:Frontotemporal lobar degeneration
0 Companies
0 Drugs
Success rate
D000093902:Mixed dementias
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Rivastigmine | Rivastigmine Teva |  | 2009-04-17 |  |  |
| Risperidone | Uzedy | 2025-01-12 | 2023-04-28 |  |  | |
| Risperidone | Risperidone |  | 2023-12-05 |  |  | |
| Taro Pharmaceutical | Citalopram | Citalopram |  | 2006-03-22 |  |  |
| Risperidone | Risperidone |  | 2011-02-07 |  |  | |
| Glenmark Pharmaceuticals | Citalopram | Citalopram |  | 2009-02-27 |  |  |
| Mylan | Citalopram | Citalopram |  | 2004-11-05 |  |  |
| Johnson & Johnson | Risperidone | Risperdal |  | 1993-12-29 | $374 M | Y2022 |
| Cipla | Citalopram | Citalopram |  | 2006-10-03 |  |  |
| Sandoz | Risperidone | Risperidone |  | 2009-12-22 |  |  |
| Rivastigmine | Rivastigmine Sandoz |  | 2009-12-10 |  |  | |
| Novartis | Rivastigmine | Exelon |  | 1998-05-11 |  |  |
| Rivastigmine | Prometax |  | 1998-12-03 |  |  |
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
68%13/19
Phase 2
45%23/51
Phase 3
22%29/134
Approved: 6Overall Success rate: 7%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use